期刊文献+

头颈肿瘤病人鼻饲并发症的护理进展

下载PDF
导出
摘要 头颈肿瘤患者需要进行鼻饲,鼻饲治疗法主要是指导管经过鼻腔插入其胃内,于管内将流质食物、药物和水分灌注其中。在临床之中,昏迷的或者或者消化道疾病、食管狭窄、肿瘤、颅外伤导致患者无法进食的时候,为了保障患者可摄入充足的热量、蛋白质,需要经过导管给予营养液和流质食物。头颈肿瘤患者,因为肿瘤消耗,患者伴有长期的进食障碍,在手术之前患者会出现体质下降,患者体内的营养物质出现严重的缺失,手术后因病情需要不能经口进食。本文就头颈肿瘤患者纳入研究范围之内,探究头颈肿瘤患者鼻饲并发症的相关护理干预措施。
出处 《医学食疗与健康》 2018年第12期294-294,共1页 Medical Diet and Health
  • 相关文献

参考文献9

二级参考文献62

  • 1李彩云.癌症病人发生抑郁的相关因素及护理对策[J].护理研究,2004,18(7):1140-1142. 被引量:17
  • 2陈映兰,黄鹏,黄丽侬.甲状腺次全切除术后2种不同引流方法的效果比较[J].当代护士(中旬刊),2007,14(11):9-10. 被引量:5
  • 3GAUTAM A P, FERNANDES D J, VIDYASAGAR M S, et al. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy-a randomized controlled trial [J]. Support Care Cancer, 2013, 21(5): 1421-1428.
  • 4SATHEESHKUMAR P S, MOHAN M P. Tachykinin peptide, substance P, and its receptor NK-1R play an important role in alimentary tract mucosal inflammation during cytotoxic therapy [J]. Dig Dis Sci, 2014, 59(12): 2864-2873.
  • 5UANTAM A P, FERMANDES D J, VIDYASAGER M S, et al. Effect of low level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receivin chemoradiotherapy-a randomized controlled trial [J]. Support Care Cancer, 2013, 21(5): 1421-1428.
  • 6FUKAZAWA M, KAWAGUCHI H, SHIGEMATSU H, et al. High incidencerate of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy(FEClO0) [J]. Gan To Kagaku Ryoho, 2012, 39(3): 395-398.
  • 7RICCI F, PARADISI A, SILVERI S L, et al. Adverse skin reactions during treatment with cetuximab plus radiotherapy: multidisciplinary approach to minimise radio-chemotherapy interruption [J]. J Dermatol Treat, 2014, 26(2): 1-20.
  • 8EPPERLY M W, FRANICOLA D, ZHANG X, et al. Effect of EGFR antagonists gefitinib (iressa) and C225 (Cetuximab) on MnSOD-plasmid liposome transgene radiosensitization of a murine squamous cell carcinoma cell line [J]. Vivo, 2006, 20(68): 791-796.
  • 9BERG E A, PLATTS-MILLS T A, COMMINS S P. Drug allergens and food-the cetuximab and galaetose-a-1,3- galactose story [J]. Ann Allergy Ashma Immunol, 2014, 112(2): 97-101.
  • 10GARRIDO G, TIKHOMIROV I A, RABASA A, et al. Bivalent binding by intermediate affinity of nimotuzurnab: a contribution to explain antibody clinical profile [J]. Cancer Biol Ther, 2011, 11(4): 373-382.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部